US STOCKS ON THE MOVE-Salesforce, Brown & Brown, IonQ, Harmony Biosciences

By Reuters News

Oct 12 (Reuters) - US stock indexes were on track for a muted open on Monday as investors watched oil prices and global events ahead of crucial bank earnings and inflation data due later in the week that are widely expected to influence the central bank's rate path. .N


** Bristol Myers BMY.N:

BUZZ - Bristol Myers rises on positive trial results for cancer and lung disease drugs


** Dauch Corp DCH.N:

BUZZ - Dauch Corp rises after naming new finance chief


** Salesforce CRM.N:

BUZZ - BofA double-upgrades co to 'buy'; shares rise


** Brown & Brown BRO.N:

BUZZ - TD Cowen starts coverage with 'buy'


** IonQ IONQ.N:

BUZZ - Shares fall on $1.3 billion acquisition of cybersecurity co Elisity


** Harmony Biosciences HRMY.O:

BUZZ - CEO Dayno to retire, COO to take over; shares fall


** First Tracks Biotherapeutics TRAX.O:

BUZZ - Shares surge on positive results from celiac disease drug trial


** Enovix ENVX.O:

BUZZ - Shares rise on higher Q3 prelim revenue


** GoDaddy GDDY.N:

BUZZ - RBC downgrades rating on AI disruption fears


** Biogen BIIB.O:

BUZZ - J.P. Morgan upgrades to 'overweight', shares rise


** IREN IREN.O:

BUZZ - Shares rise on report of multi-year cloud deal with Anthropic

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.